Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Infectious Diseases, Hopitaux Universitaires de Geneve, Geneva, Switzerland.
BMJ Open. 2020 Jun 4;10(6):e033640. doi: 10.1136/bmjopen-2019-033640.
With the widespread use of electronic health records and handheld electronic devices in hospitals, informatics-based antimicrobial stewardship interventions hold great promise as tools to promote appropriate antimicrobial drug prescribing. However, more research is needed to evaluate their optimal design and impact on quantity and quality of antimicrobial prescribing.
Use of smartphone-based digital stewardship applications (apps) with local guideline directed empirical antimicrobial use by physicians will be compared with antimicrobial prescription as per usual as primary outcome in three hospitals in the Netherlands, Sweden and Switzerland. Secondary outcomes will include antimicrobial use metrics, clinical and process outcomes. A multicentre stepped-wedge cluster randomised trial will randomise entities defined as wards or specialty regarding time of introduction of the intervention. We will include 36 hospital entities with seven measurement periods in which the primary outcome will be measured in 15 participating patients per time period per cluster. At participating wards, patients of at least 18 years of age using antimicrobials will be included. After a baseline period of 2-week measurements, six periods of 4 weeks will follow in which the intervention is introduced in 6 wards (in three hospitals) until all 36 wards have implemented the intervention. Thereafter, we allow use of the app by everyone, and evaluate the sustainability of the app use 6 months later.
This protocol has been approved by the institutional review board of each participating centre. Results will be disseminated via media, to healthcare professionals via professional training and meetings and to researchers via conferences and publications.
ClinicalTrials.gov registry (NCT03793946). Stage; pre-results.
随着电子病历和手持电子设备在医院中的广泛应用,基于信息学的抗菌药物管理干预措施作为促进适当使用抗菌药物的工具具有很大的潜力。然而,需要进一步研究来评估其最佳设计及其对抗菌药物处方数量和质量的影响。
将智能手机基础数字化管理应用程序(app)与当地指南指导下的医生经验性抗菌药物使用进行比较,将其作为荷兰、瑞典和瑞士 3 家医院的主要结局,评估其对抗菌药物处方的影响。次要结局将包括抗菌药物使用指标、临床和流程结局。采用多中心阶梯式楔形集群随机试验,将实体(如病房或专科)按干预时间进行分组。我们将纳入 36 个医院实体,每个医院实体将进行 7 个测量周期,每个集群每个时间周期将有 15 名参与患者测量主要结局。在参与病房中,将纳入至少 18 岁且正在使用抗菌药物的患者。在基线测量期(2 周)之后,将进行 6 个为期 4 周的测量周期,在此期间,将在 6 个病房(在 3 家医院)中引入干预措施,直到所有 36 个病房都实施了干预措施。此后,允许所有人使用该应用程序,并在 6 个月后评估该应用程序的可持续性。
本方案已获得每个参与中心机构审查委员会的批准。研究结果将通过媒体向医疗保健专业人员传播,通过专业培训和会议向他们传播,通过会议和出版物向研究人员传播。
ClinicalTrials.gov 注册(NCT03793946)。阶段:前结果。